Trial intelligence / Profile preview

BMAC and Bovine Graft for Sinus Floor Elevation

NCT05730400Completed

Sponsor
Cairo University
Start
Oct 2022
Primary completion
Aug 2023
Modality
Stem Cell Therapies
Countries
1
01

Overview

Randomised, open-label trial of autologous bone marrow cell concentrate in Maxillary atrophy, sponsored by Cairo University. Primary endpoint: Histological assessment of bone core biopsy at 4 months. Started Oct 2022; status: completed.

02

Drugs

autologous bone marrow cell concentrate
03

Conditions

Maxillary atrophy

Beyond the preview

Go deeper on NCT05730400.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05730400.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call